Mixed Chimerism, Lymphocyte Recovery, and Evidence for Early Donor-Specific Unresponsiveness in Patients Receiving Combined Kidney and Bone Marrow Transplantation to Induce Tolerance

Background. We have previously reported operational tolerance in patients receiving human leukocyte antigen-mismatched combined kidney and bone marrow transplantation (CKBMT). We now report on transient multilineage hematopoietic chimerism and lymphocyte recovery in five patients receiving a modified CKBMT protocol and evidence for early donor-specific unresponsiveness in one of these patients. Methods. Five patients with end-stage renal disease received CKBMT from human leukocyte antigen-mismatched, haploidentical living-related donors after modified nonmyeloablative conditioning. Polychromatic flow cytometry was used to assess multilineage chimerism and lymphocyte recovery posttransplant. Limiting dilution analysis was used to assess helper T-lymphocyte reactivity to donor antigens. Results. Transient multilineage mixed chimerism was observed in all patients, but chimerism became undetectable by 2 weeks post-CKBMT. A marked decrease in T- and B-lymphocyte counts immediately after transplant was followed by gradual recovery. Initially, recovering T cells were depleted of CD45RA+/CD45RO− “naïve-like” cells, which have shown strong recovery in two patients, and CD4:CD8 ratios increased immediately after transplant but then declined markedly. Natural killer cells were enriched in the peripheral blood of all patients after transplant. For subject 2, a pretransplant limiting dilution assay revealed T helper cells recognizing both donor and third-party peripheral blood mononuclear cells. However, the antidonor response was undetectable by day 24, whereas third-party reactivity persisted. Conclusion. These results characterize the transient multilineage mixed hematopoietic chimerism and recovery of lymphocyte subsets in patients receiving a modified CKBMT protocol. The observations are relevant to the mechanisms of donor-specific tolerance in this patient group.

[1]  M. Sykes,et al.  Homeostatic Expansion and Phenotypic Conversion of Human T Cells Depend on Peripheral Interactions with APCs , 2010, The Journal of Immunology.

[2]  A. Demetris,et al.  NK Cells Delay Allograft Rejection in Lymphopenic Hosts by Downregulating the Homeostatic Proliferation of CD8+ T Cells , 2010, The Journal of Immunology.

[3]  Y. Lau,et al.  Natural killer cells become tolerogenic after interaction with apoptotic cells , 2010, European journal of immunology.

[4]  J. D. Di Santo,et al.  IL-15 trans-presentation promotes human NK cell development and differentiation in vivo , 2009, The Journal of experimental medicine.

[5]  Sami Al-Hajjar,et al.  A role for interleukin-12/23 in the maturation of human natural killer and CD56+ T cells in vivo. , 2008, Blood.

[6]  V. Sharma,et al.  HLA-mismatched renal transplantation without maintenance immunosuppression. , 2008, The New England journal of medicine.

[7]  S. Saidman,et al.  Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine. , 2007, Experimental hematology.

[8]  K. Wucherpfennig,et al.  Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. , 2007, Immunity.

[9]  M. Sykes.  Mechanisms of tolerance induced via mixed chimerism. , 2007, Frontiers in bioscience : a journal and virtual library.

[10]  J. Stein‐Streilein,et al.  Invariant NKT Cells and Tolerance , 2007, International reviews of immunology.

[11]  R. Colvin,et al.  Myeloma Responses and Tolerance Following Combined Kidney and Nonmyeloablative Marrow Transplantation: In Vivo and In Vitro Analyses , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  S. Saidman,et al.  NK cell recovery, chimerism, function, and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CD2 mAb, Medi-507. , 2003, Experimental hematology.

[13]  S. Saidman,et al.  Early host CD8 T-cell recovery and sensitized anti-donor interleukin-2-producing and cytotoxic T-cell responses associated with marrow graft rejection following nonmyeloablative allogeneic bone marrow transplantation. , 2003, Experimental hematology.

[14]  R. Hurren,et al.  Activated, But Not Resting, T Cells Can Be Recognized and Killed by Syngeneic NK Cells 1 , 2003, The Journal of Immunology.

[15]  M. Caligiuri,et al.  The biology of human natural killer-cell subsets. , 2001, Trends in immunology.

[16]  S. Seki,et al.  Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells , 2001, Immunology.

[17]  R. Colvin,et al.  Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance. , 1999, Transplantation.

[18]  F. Delmonico,et al.  Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. , 1999, Transplantation.

[19]  A. Tosti,et al.  Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. , 1999, Blood.

[20]  M. Hirokawa,et al.  Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-beta: contrasting effects of anti-CD2 and anti-CD3. , 1998, Journal of immunology.

[21]  W. Mayr,et al.  Strategy to Detect Chimerism in Allogeneic Bone Marrow Transplant Recipients by PCR‐Amplification Fragment Length Polymorphism Analysis of Microsatellite Polymorphisms , 1995, Vox sanguinis.

[22]  R. Colvin,et al.  Mixed Allogeneic Chimerism And Renal Allograft Tolerance In Cynomolgus Monkeys , 1995, Transplantation.

[23]  R. Jacobs,et al.  CD16- CD56+ natural killer cells after bone marrow transplantation. , 1992, Blood.

[24]  K. Atkinson,et al.  Reconstruction of the haemopoietic and immune systems after marrow transplantation. , 1990, Bone marrow transplantation.

[25]  R. Bray,et al.  Two populations of CD56 (Leu-19)+/CD16+ cells in bone marrow transplant recipients. , 1990, Bone marrow transplantation.

[26]  C. Rosse,et al.  The primary role of murine bone marrow in the production of natural killer cells. A cytokinetic study. , 1987, Journal of immunology.

[27]  R. Storb,et al.  T-cell subpopulations identified by monoclonal antibodies after human marrow transplantation. I. Helper-inducer and cytotoxic-suppressor subsets , 1982 .

[28]  R. van Furth,et al.  THE ORIGIN AND KINETICS OF MONONUCLEAR PHAGOCYTES , 1968, The Journal of experimental medicine.

[29]  A. Ashkar,et al.  Characterization and IL-15 dependence of NK cells in humanized mice. , 2011, Immunobiology.

[30]  C. Mackall,et al.  Age-dependent incidence, time course, and consequences of thymic renewal in adults. , 2005, The Journal of clinical investigation.